Literature DB >> 16430923

Brain calcifications induce neurological dysfunction that can be reversed by a bone drug.

Jeffrey A Loeb1, Sayyed A Sohrab, Mabubul Huq, Darren R Fuerst.   

Abstract

Perivascular calcifications within the brain form in response to a variety of insults. While considered by many to be benign, these calcium phosphate deposits or "brain stones" can become large and are associated with neurological symptoms that range from seizures to parkinsonian symptoms. Here we hypothesize that the high concentrations of calcium in these deposits produce reversible, toxic effects on neurons that can be overcome with "bone" drugs that chelate solid phase calcium phosphates. We present preliminary findings that suggest a direct association between progressive neurological symptoms and brain calcification and the symptomatic improvement of seizures, headaches, and parkinsonian symptoms in patients treated with the bisphosphonate drug disodium etidronate, normally used to treat bone diseases. Future, longitudinal epidemiological studies and randomized trials will be needed to determine the true relationship between brain stones and neurological disorders as well as the utility of bisphosphonates in their prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430923     DOI: 10.1016/j.jns.2005.11.033

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Extensive vascular mineralization in the brain of a chimpanzee (Pan troglodytes).

Authors:  Fawn R Connor-Stroud; William D Hopkins; Todd M Preuss; Zachary Johnson; Xiaodong Zhang; Prachi Sharma
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

2.  Cortical calcification in Sturge-Weber Syndrome on MRI-SWI: relation to brain perfusion status and seizure severity.

Authors:  Jianlin Wu; Bisher Tarabishy; Jiani Hu; Yanwei Miao; Zhaocheng Cai; Yang Xuan; Michael Behen; Meng Li; Yongquan Ye; Richard Shoskey; E Mark Haacke; Csaba Juhász
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

Review 3.  Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

Authors:  Yvonne Nitschke; Frank Rutsch
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

Review 4.  A Multidisciplinary Consensus for Clinical Care and Research Needs for Sturge-Weber Syndrome.

Authors:  Alejandro J De la Torre; Aimee F Luat; Csaba Juhász; Mai Lan Ho; Davis P Argersinger; Kara M Cavuoto; Mabel Enriquez-Algeciras; Stephanie Tikkanen; Paula North; Craig N Burkhart; Harry T Chugani; Karen L Ball; Anna Lecticia Pinto; Jeffrey A Loeb
Journal:  Pediatr Neurol       Date:  2018-04-18       Impact factor: 3.372

Review 5.  Treatment of neurocysticercosis: current status and future research needs.

Authors:  T E Nash; G Singh; A C White; V Rajshekhar; J A Loeb; J V Proaño; O M Takayanagui; A E Gonzalez; J A Butman; C DeGiorgio; O H Del Brutto; A Delgado-Escueta; C A W Evans; R H Gilman; S M Martinez; M T Medina; E J Pretell; J Teale; H H Garcia
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

6.  Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line.

Authors:  Paola Maura Tricarico; Angeladine Epate; Fulvio Celsi; Sergio Crovella
Journal:  Inflammopharmacology       Date:  2017-06-23       Impact factor: 4.473

7.  Clinical and metabolic correlates of cerebral calcifications in Sturge-Weber syndrome.

Authors:  Vinod K Pilli; Michael E Behen; Jiani Hu; Yang Xuan; James Janisse; Harry T Chugani; Csaba Juhász
Journal:  Dev Med Child Neurol       Date:  2017-04-11       Impact factor: 5.449

8.  Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats.

Authors:  Timo Sarajärvi; Anu Lipsanen; Petra Mäkinen; Sirpa Peräniemi; Hilkka Soininen; Annakaisa Haapasalo; Jukka Jolkkonen; Mikko Hiltunen
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

9.  Brain stones revisited-between a rock and a hard place.

Authors:  Froilan G Celzo; Caroline Venstermans; Frank De Belder; Johan Van Goethem; Luc van den Hauwe; Thijs van der Zijden; Maurits Voormolen; Tomas Menovsky; Andrew Maas; Paul M Parizel
Journal:  Insights Imaging       Date:  2013-09-11

10.  Primary brain calcification in patients undergoing treatment with the biphosphanate alendronate.

Authors:  J R M Oliveira; M F Oliveira
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.